# Study of Fludarabine Based Conditioning for Allogeneic Stem Cell Transplantation for Myelofibrosis

> **NCT00572897** · PHASE2 · COMPLETED · sponsor: **John Mascarenhas** · enrollment: 66 (actual)

## Conditions studied

- Myelofibrosis

## Interventions

- **DRUG:** Fludarabine, Melphalan +/- ATG

## Key facts

- **NCT ID:** NCT00572897
- **Lead sponsor:** John Mascarenhas
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2011-08
- **Final completion:** 2015-06-15
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2017-05-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00572897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00572897, "Study of Fludarabine Based Conditioning for Allogeneic Stem Cell Transplantation for Myelofibrosis". Retrieved via AI Analytics 2026-07-31 from https://api.ai-analytics.org/clinical/NCT00572897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*